These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19409033)

  • 21. Prognosis of patients with multifocal glioblastoma: a case-control study.
    Patil CG; Yi A; Elramsisy A; Hu J; Mukherjee D; Irvin DK; Yu JS; Bannykh SI; Black KL; Nuño M
    J Neurosurg; 2012 Oct; 117(4):705-11. PubMed ID: 22920963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival with glioblastoma multiforme.
    Krex D; Klink B; Hartmann C; von Deimling A; Pietsch T; Simon M; Sabel M; Steinbach JP; Heese O; Reifenberger G; Weller M; Schackert G;
    Brain; 2007 Oct; 130(Pt 10):2596-606. PubMed ID: 17785346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elderly patients with glioblastoma multiforme treated with concurrent temozolomide and standard- versus abbreviated-course radiotherapy.
    Chang-Halpenny CN; Yeh J; Lien WW
    Perm J; 2015; 19(1):15-20. PubMed ID: 25663202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
    Roh TH; Park HH; Kang SG; Moon JH; Kim EH; Hong CK; Ahn SS; Choi HJ; Cho J; Kim SH; Lee SK; Kim DS; Kim SH; Suh CO; Lee KS; Chang JH
    Medicine (Baltimore); 2017 Jul; 96(27):e7422. PubMed ID: 28682902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors influencing clinical outcomes of malignant glioblastoma multiforme: clinical, immunophenotypic, and fluorescence in situ hybridization findings for 1p19q in 816 chinese cases.
    Qin JJ; Liu ZX; Wang JM; Du J; Xu L; Zeng C; Han W; Li ZD; Xie J; Li GL
    Asian Pac J Cancer Prev; 2015; 16(3):971-7. PubMed ID: 25735391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma: Overview of Disease and Treatment.
    Davis ME
    Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S2-8. PubMed ID: 27668386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future?
    Veliz I; Loo Y; Castillo O; Karachaliou N; Nigro O; Rosell R
    Ann Transl Med; 2015 Jan; 3(1):7. PubMed ID: 25705639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of MGMT methylation in Glioblastoma Multiforme prognosis.
    Rao AM; Quddusi A; Shamim MS
    J Pak Med Assoc; 2018 Jul; 68(7):1137-1139. PubMed ID: 30317322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten-year review of survival and management of malignant glioma in Hong Kong.
    Chan DT; Hsieh SY; Lau CK; Kam MK; Loong HH; Tsang WK; Poon DM; Poon WS
    Hong Kong Med J; 2017 Apr; 23(2):134-9. PubMed ID: 27909268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent glioblastoma multiforme: a review of natural history and management options.
    Hou LC; Veeravagu A; Hsu AR; Tse VC
    Neurosurg Focus; 2006 Apr; 20(4):E5. PubMed ID: 16709036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.
    Wick W; Dettmer S; Berberich A; Kessler T; Karapanagiotou-Schenkel I; Wick A; Winkler F; Pfaff E; Brors B; Debus J; Unterberg A; Bendszus M; Herold-Mende C; Eisenmenger A; von Deimling A; Jones DTW; Pfister SM; Sahm F; Platten M
    Neuro Oncol; 2019 Jan; 21(1):95-105. PubMed ID: 30277538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review).
    Khabibov M; Garifullin A; Boumber Y; Khaddour K; Fernandez M; Khamitov F; Khalikova L; Kuznetsova N; Kit O; Kharin L
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35445737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma.
    Sugimoto K; Ideguchi M; Kimura T; Kajiwara K; Imoto H; Sadahiro H; Ishii A; Kawano H; Ikeda E; Suzuki M
    Brain Tumor Pathol; 2016 Apr; 33(2):137-46. PubMed ID: 26667174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New molecularly targeted therapies for glioblastoma multiforme.
    Polivka J; Polivka J; Rohan V; Topolcan O; Ferda J
    Anticancer Res; 2012 Jul; 32(7):2935-46. PubMed ID: 22753758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide.
    Saito T; Sugiyama K; Ikawa F; Yamasaki F; Ishifuro M; Takayasu T; Nosaka R; Nishibuchi I; Muragaki Y; Kawamata T; Kurisu K
    World Neurosurg; 2017 Jan; 97():21-26. PubMed ID: 27693246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Glioblastoma: Molecular analysis and its clinical implications].
    Castañeda CA; Casavilca S; Orrego E; García-Corrochano P; Deza P; Heinike H; Castillo M; Belmar-Lopez C; Ojeda L
    Rev Peru Med Exp Salud Publica; 2015; 32(2):316-25. PubMed ID: 26338394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glioblastoma Multiforme and Genetic Mutations: The Issue Is Not Over Yet. An Overview of the Current Literature.
    Montemurro N
    J Neurol Surg A Cent Eur Neurosurg; 2020 Jan; 81(1):64-70. PubMed ID: 31550738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
    Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
    J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioblastoma biomarkers from bench to bedside: advances and challenges.
    Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E
    Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.